Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
Clinical trial NCT02414958 · COMPLETED
Trial details
- NCT number
- NCT02414958
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-30
- Primary completion
- 2017-04-20
- Enrollment
- 730
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.